Jeffrey Jacob
Chief Executive Officer bij CANCER PREVENTION PHARMACEUTICALS INC
Vermogen: 1 $ op 31-03-2024
Profiel
Jeffrey E.
Jacob is the founder of Systems Medicine, Inc., which was founded in 2004.
He held the title of President & Chief Executive Officer from 2004 to 2008.
Mr. Jacob's current job(s) include being the Chairman & Chief Executive Officer at Cancer Prevention Pharmaceuticals, Inc. since 2008, Chairman at Research Corporation Technologies, Inc., Director at Critical Path Institute, and Director at Panbela Therapeutics, Inc. since 2022.
Mr. Jacob's former job(s) include being the Chief Program Officer at Critical Path Institute and Senior Vice President at Research Corporation Technologies, Inc. from 1987 to 2004.
Mr. Jacob's education history includes a graduate degree from Massachusetts Institute of Technology and an undergraduate degree from the University of Arizona.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PANBELA THERAPEUTICS INC
0.00% | 27-03-2024 | 1 ( 0.00% ) | 1 $ | 31-03-2024 |
Actieve functies van Jeffrey Jacob
| Bedrijven | Functie | Begin |
|---|---|---|
| CANCER PREVENTION PHARMACEUTICALS INC | Chief Executive Officer | 09-06-2008 |
| PANBELA THERAPEUTICS, INC. | Director/Board Member | 15-06-2022 |
Research Corporation Technologies, Inc.
 Research Corporation Technologies, Inc. Financial ConglomeratesFinance Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ. | Chairman | - |
Critical Path Institute
 Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Director/Board Member | - |
Eerdere bekende functies van Jeffrey Jacob
| Bedrijven | Functie | Einde |
|---|---|---|
Systems Medicine, Inc.
 Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Chief Executive Officer | 01-01-2008 |
Research Corporation Technologies, Inc.
Research Corporation Technologies, Inc. Financial ConglomeratesFinance Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ. | Corporate Officer/Principal | 01-01-2004 |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Corporate Officer/Principal | - |
Opleiding van Jeffrey Jacob
| Massachusetts Institute of Technology | Graduate Degree |
| University of Arizona | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PANBELA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Cancer Prevention Pharmaceuticals, Inc.
 Cancer Prevention Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cancer Prevention Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases and gastrointestinal conditions. The company’s pipeline consists of Gastrointestinal and Orphan. Cancer Prevention Pharmaceuticals was founded by Dr. Frank Meyskens and Gene Gerner in June 9, 2008 and is headquartered in Tucson, AZ. | Health Technology |
Systems Medicine, Inc.
Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Health Technology |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Commercial Services |
Research Corporation Technologies, Inc.
Research Corporation Technologies, Inc. Financial ConglomeratesFinance Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ. | Finance |
